(Q35787450)

10 August 2017

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries (English)

1 reference

World Health Organization

10 August 2017

0 references

Mycobacterium tuberculosis

0 references

1 reference

69

1 reference

10 August 2017

Marieke J. Van Der Werf

Marieke J van der Werf

59

0 references

Andreas Sandgren

Andreas Sandgren

50

0 references

Justin T Denholm

Justin Denholm

18

0 references

Helen R. Stagg

Helen R Stagg

55

0 references

Mario Raviglione

Mario Raviglione

Giovanni Battista Migliori

72

0 references

Giovanni Battista Migliori

40

0 references

Andreas Reis

Andreas Reis

48

0 references

Ibrahim Abubakar

3

Ibrahim Abubakar

1 reference

10 August 2017

37

Knut Lönnroth

1 reference

10 August 2017

13

Richard Chaisson

1 reference

10 August 2017

39

Dick Menzies

1 reference

10 August 2017

34

Katharina Kranzer

1 reference

10 August 2017

21

Nathan Ford

1 reference

10 August 2017

52

Holger J Schünemann

1 reference

Marije Vonk Noordegraaf-Schouten

10 August 2017

24

Enrico Girardi

0 references

66

Marije Vonk Noordegraaf-Schouten

1 reference

10 August 2017

46

Anouk Oordt-Speets

1 reference

10 August 2017

2

Alberto Matteelli

1 reference

10 August 2017

9

Judith Bruchfeld

1 reference

10 August 2017

Jean-Pierre Zellweger

71

Jean Pierre Zellweger

1 reference

10 August 2017

36

Philip LoBue

1 reference

10 August 2017

65

Constantia Voniatis

1 reference

10 August 2017

58

Mukund Uplekar

1 reference

10 August 2017

5

Annabel Baddeley

1 reference

10 August 2017

23

Chris Gilpin

1 reference

10 August 2017

28

Malgorzata Grzemska

1 reference

10 August 2017

67

Diana Weil

1 reference

10 August 2017

42

Ya Diul Mukadi

1 reference

10 August 2017

57

Tamara Tayeb

1 reference

10 August 2017

32

Ernesto Jaramillo

1 reference

10 August 2017

35

Christian Lienhardt

1 reference

10 August 2017

Haileyesus Getahun

1

1 reference

10 August 2017

Mohamed Abdel Aziz

4

1 reference

10 August 2017

Draurio Barreira

6

1 reference

10 August 2017

Saskia Den Boon

7

1 reference

10 August 2017

Susana Marta Borroto Gutierrez

8

1 reference

10 August 2017

Erlina Burhan

10

1 reference

10 August 2017

Solange Cavalcante

11

1 reference

10 August 2017

Rolando Cedillos

12

1 reference

10 August 2017

Cynthia Bin-Eng Chee

14

1 reference

10 August 2017

Lucy Chesire

15

1 reference

10 August 2017

Elizabeth Corbett

16

1 reference

10 August 2017

Masoud Dara

17

1 reference

10 August 2017

Gerard de Vries

19

1 reference

10 August 2017

Dennis Falzon

20

1 reference

10 August 2017

Margaret Gale-Rowe

22

1 reference

10 August 2017

Un-Yeong Go

25

1 reference

10 August 2017

Darshini Govindasamy

26

1 reference

10 August 2017

Alison D Grant

27

1 reference

10 August 2017

Ross Harris

29

1 reference

10 August 2017

C Robert Horsburgh

30

1 reference

10 August 2017

Asker Ismayilov

31

1 reference

10 August 2017

Sandra Kik

33

1 reference

10 August 2017

Guy Marks

38

1 reference

10 August 2017

Davide Mosca

41

1 reference

10 August 2017

Alwyn Mwinga

43

1 reference

10 August 2017

Lisa Nelson

44

1 reference

10 August 2017

Nobuyuki Nishikiori

45

1 reference

10 August 2017

Molebogeng Xheedha Rangaka

47

1 reference

10 August 2017

Lisa Rotz

49

1 reference

10 August 2017

Monica Sañé Schepisi

51

1 reference

10 August 2017

Surender Kumar Sharma

53

1 reference

10 August 2017

Giovanni Sotgiu

54

1 reference

10 August 2017

Timothy R Sterling

56

1 reference

10 August 2017

Wim Vandevelde

60

1 reference

10 August 2017

Femke van Kessel

61

1 reference

10 August 2017

Anna van't Hoog

62

1 reference

10 August 2017

Jay K Varma

63

1 reference

10 August 2017

Natalia Vezhnina

64

1 reference

10 August 2017

Karin Weyer

68

1 reference

10 August 2017

Takashi Yoshiyama

70

1 reference

10 August 2017

24 September 2015

1 reference

European Respiratory Journal

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

6

1 reference

10 August 2017

1563-1576

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

10 August 2017

1 reference

Latent Mycobacterium tuberculosis infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Towards tuberculosis elimination: an action framework for low-incidence countries

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Latent tuberculous infection: ethical considerations in formulating public health policy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Treatment of latent tuberculosis infection: a network meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Three months of rifapentine and isoniazid for latent tuberculosis infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Priorities for screening and treatment of latent tuberculosis infection in the United States

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Treatment of latent tuberculosis infection: An update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Isoniazid preventive therapy and risk for resistant tuberculosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Can the poor adhere? Incentives for adherence to TB prevention in homeless adults.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Cultural case management of latent tuberculosis infection.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Incentives vs outreach workers for latent tuberculosis treatment in drug users

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

The prognosis of a positive tuberculin reaction in childhood and adolescence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

WHO's new end TB strategy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

An ethics framework for public health.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

6 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4664608

Public health impact of targeted tuberculosis screening in public schools

6 December 2018

1 reference

12 December 2020

Increasing Latino Adolescents’ Adherence to Treatment for Latent Tuberculosis Infection: A Controlled Trial

1 reference

12 December 2020

Tuberculin screening: cost-effectiveness analysis of various testing schedules

1 reference

12 December 2020

Preventive Therapy for Tuberculosis in HIV-Infected Persons Analysis of Policy Options Based on Tuberculin Status and CD4 + Cell Count

1 reference

12 December 2020

Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country

1 reference

12 December 2020

The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study

1 reference

12 December 2020

Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort

1 reference

12 December 2020

Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection

1 reference

12 December 2020

10.1183/13993003.01245-2015

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference